Lexicon Pharmaceuticals LXRX Property, plant and equipment at cost
Property, plant and equipment at cost at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's property, plant and equipment at cost.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's property, plant and equipment at cost?
- Lexicon Pharmaceuticals (LXRX) reported property, plant and equipment at cost of $4.57M in Q1 2026.
- How has Lexicon Pharmaceuticals's property, plant and equipment at cost changed year-over-year?
- Lexicon Pharmaceuticals's property, plant and equipment at cost decreased by 0.0% year-over-year, from $4.57M to $4.57M.
- What is the long-term trend for Lexicon Pharmaceuticals's property, plant and equipment at cost?
- Over 3 years (2020 to 2025), Lexicon Pharmaceuticals's property, plant and equipment at cost has grown at a -9.2% compound annual growth rate (CAGR), from $6.11M to $4.57M.